COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire

Mostrar otras versiones (1)

Effective vaccines against the SARS-CoV-2 are already available and offer a promising action to control the COVID-19 pandemic. IBD patients on biological agents accept the vaccine as well as an additional dose if recommended. BACKGROUND: Vaccination against COVID-19 prevents its severe forms and ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Laura, Carrillo-Palau, Marta, Alonso-Abreu, Inmaculada, Reygosa, Cristina, Hernández-Alvarez, Noemi, Amaral, Carla, Hernández, Anjara, Benítez-Zafra, Federica, Pérez-González, Fabiola, Quintana-Díaz, Haridian, Hernandez-Guerra, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193138/
http://dx.doi.org/10.1016/j.gastre.2022.05.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193138/
http://dx.doi.org/10.1016/j.gastre.2022.05.009

Ejemplares similares